(Press-News.org) Dementia patients may benefit from a promising new treatment called Cerebrolysin, according to the results of a systematic review published in The Cochrane Library. The authors brought together the most up-to-date evidence on Cerebrolysin as a treatment for vascular dementia.
Vascular dementia is a common form of dementia caused by damage to the network of blood vessels supplying the brain. Some of the symptoms are similar to those associated with Alzheimer's disease and stroke but in particular those with vascular dementia often experience difficulty thinking quickly, concentrating and communicating, as well as seizures and severe confusion.1 There is currently no definitive treatment for vascular dementia. Cerebrolysin is a drug treatment made from pig brain proteins that has produced positive results against vascular dementia, although inconsistently.
The researchers reviewed data from six randomized controlled trials involving 597 people in total. All were given Cerebrolysin intravenously in different daily concentrations and for different treatment periods, from a few weeks to three years, depending on the trial. Compared to standard care alone or placebos, Cerebrolysin significantly improved cognitive function, which was assessed with scales testing recall, arithmetic or other cognitive abilities. It had a small positive effect on patients' overall clinical state. There was also some suggestion that long-term treatment was associated with greater benefits, although only two trials looked at long-term effects.
"Our review suggests that Cerebrolysin can help improve cognitive and global function in patients with mild to moderate severity vascular dementia," said researcher Li He of the Department of Neurology at Sichuan University in Sichuan, China. "The results are promising but due to low numbers of trials, inconsistencies between trials, risk of bias in the way some of the trials were conducted and lack of long-term follow-up, we cannot yet recommend Cerebrolysin as a routine treatment for vascular dementia."
None of those involved in studies reported serious side effects due to taking the drug and non-serious side effects were no more common in those who took the drug compared to control groups. "This indicates to us that Cerebrolysin is safe and well tolerated by patients with vascular dementia," said He. "But the fact that it has to be given in regular intravenous infusions means it could be impractical for use on a large scale."
### 1. http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=161
URL Upon publication: http://doi.wiley.com/10.1002/14651858.CD008900.pub2
Dementia: Cerebrolysin shows promise
2013-01-31
ELSE PRESS RELEASES FROM THIS DATE:
Chronic hepatitis C: Interferon may be harmful in re-treatment
2013-01-31
People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are likely to experience a variety of adverse effects, according to an updated systematic review published in The Cochrane Library.
Hepatitis C affects around 170 million people worldwide. In some cases, infection leads to chronic liver disease, liver failure or liver cancer, eventually resulting in death. Treatment is based on antiviral drugs.
Interferon ...
Tuberculosis: WHO-endorsed test offers rapid detection
2013-01-31
A diagnostic test for tuberculosis (TB) can accurately and quickly detect both TB and drug-resistant strains, according to a new study. The authors of a new systematic review assessing the diagnostic accuracy of the Xpert® MTB/RIF test published in The Cochrane Library say their study can provide timely advice for clinicians and policymakers in countries where TB is a major public health problem.
Millions of people develop TB every year. Around 13% of cases occur in people living with HIV and more than a quarter of these people die as a result. Drug resistance is a major ...
New research shows complexity of global warming
2013-01-31
Global warming from greenhouse gases affects rainfall patterns in the world differently than that from solar heating, according to a study by an international team of scientists in the January 31 issue of Nature. Using computer model simulations, the scientists, led by Jian Liu (Chinese Academy of Sciences) and Bin Wang (International Pacific Research Center, University of Hawaii at Manoa), showed that global rainfall has increased less over the present-day warming period than during the Medieval Warm Period, even though temperatures are higher today than they were then. ...
Tuberculosis may lurk in bone marrow stem cells of infected patients, Stanford researchers say
2013-01-31
STANFORD, Calif. - Tuberculosis is a devastating disease that kills nearly 2 million people worldwide each year. Although antibiotics exist that can ameliorate the symptoms, the courses of therapy last for months and don't completely eradicate the disease, which frequently recurs years or decades after the initial treatment.
Now, in a classic case of bench-to-bedside research, scientists at the Stanford University School of Medicine have discovered a possible reason for the disease's resistance: The ability of the tuberculosis bacteria to infiltrate and settle down in ...
Arunachal contributes in detecting stem cells where dormant TB bacteria hide
2013-01-31
The Idu-Mishmi community and Arunachal Pradesh appeared on the world map today for its greatest contribution in studying dormant Mycobacterium in TB that has affected nearly 4 billion people in the world and causing 1.9 million deaths yearly. In India, one person is dying of TB every 3 minutes. The study details and the contribution of Idu-Mishmis of Arunachal Pradesh and RIWATCH (Research Institute of World's Ancient Traditions Cultures and Heritage) in accomplishing the study has been duly acknowledged in a research paper published in a reputed journal 'Science Translational ...
Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently
2013-01-31
PITTSBURGH, Jan. 30, 2012 –A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations of active drug in vaginal tissue than the oral tablet, suggesting that tenofovir gel should be highly effective in protecting women against HIV transmitted through vaginal sex. Yet, as unequivocal as the study's results may be, they have not been borne out in HIV prevention trials to date, leading the researchers to ...
Antibiotics cut death rate for malnourished children
2013-01-31
Severely malnourished children are far more likely to recover and survive when given antibiotics along with a therapeutic peanut-based food than children who are simply treated with the therapeutic food alone, researchers at Washington University School of Medicine in St. Louis have found.
"The findings are remarkable," says Indi Trehan, MD, lead author of the research, published Jan. 31 in The New England Journal of Medicine. "Based on previous research, we didn't think there would be much benefit from antibiotics. We did not at all expect to see a drop in the death ...
Vultures foraging far and wide face a poisonous future
2013-01-31
A first ever study of the range and habits of white-backed vultures across southern Africa shows that they often shun national parks, preferring to forage further afield on private farmland.
This behaviour and their tendency to scavenge in groups, means that vultures risk encountering dead cattle that have been administered veterinary drugs that are poisonous to them, or even poisoned carcasses intended to control other carnivores such as jackals.
The research, using Global Positioning System (GPS) satellite transmitters to track the movements of adolescent vultures, ...
Exposure to antiepileptic drug in womb linked to autism risk
2013-01-31
Children whose mothers take the antiepileptic drug sodium valproate while pregnant are at significantly increased risk of autism and other neurodevelopmental disorders, suggests a small study published online in the Journal of Neurology Neurosurgery and Psychiatry.
The authors base their findings on children born to 528 pregnant women between 2000 and 2004 in the North West of England.
Just fewer than half the mums (243) had epilepsy, all but 34 of whom took antiepileptic drugs during their pregnancy. Fifty nine mums took carbamazepine; 59 took valproate; 36 took lamotrigine; ...
Bonobos predisposed to show sensitivity to others
2013-01-31
Comforting a friend or relative in distress may be a more hard-wired behavior than previously thought, according to a new study of bonobos, which are great apes known for their empathy and close relation to humans and chimpanzees. This finding provides key evolutionary insight into how critical social skills may develop in humans. The results are published in the online journal PLOS ONE.
Researchers from the Yerkes National Primate Research Center, Emory University, observed juvenile bonobos at the Lola ya Bonobo sanctuary in the Democratic Republic of Congo engaging ...